influenza vaccines also known flu shots vaccines protect infection influenza new versions vaccines developed twice year influenza virus rapidly effectiveness varies year year provide modest high protection vaccination influenza began largescale availability united states beginning influenza vaccine world health organizations list essential world health organization us centers disease control prevention cdc recommend yearly vaccination nearly people age six months especially high european centre disease prevention control ecdc also recommends yearly vaccination high risk particularly pregnant women elderly children six months five years age certain health vaccines generally safe including people severe egg fever occurs five ten percent children vaccinated temporary muscle pains feelings tiredness may occur certain years vaccine linked increase syndrome among older people rate one case per million influenza vaccines recommended severe allergy previous versions vaccine vaccine comes inactive weakened viral forms live weakened vaccine generally recommended pregnant women children less two years old adults older people weakened immune depending type injected muscle sprayed nose injected middle layer skin intradermal vaccine available influenza vaccines used humans nonhumans human vaccine meant unless specifically identified veterinary poultry livestock vaccine worldwide spanish flu pandemic pharmacists tried everything knew everything ever heard ancient art bleeding patients administering oxygen developing new vaccines serums chiefly call hemophilus influenzae name derived fact originally considered etiological agent several types pneumococci one therapeutic measure transfusing blood recovered patients new victims showed hint viral growth embryonated hens eggs reported ernest william goodpasture colleagues vanderbilt university work extended growth influenza virus several workers including thomas francis jonas salk wilson smith macfarlane burnet leading first experimental influenza us military developed first approved inactivated vaccines influenza used world war hens eggs continued used produce virus used influenza vaccines manufacturers made improvements purity virus developing improved processes remove egg proteins reduce systemic reactivity us food drug administration fda approved influenza vaccines made growing virus cell influenza vaccines made recombinant approved plantbased influenza vaccines testedwhen clinical eggbased technology producing influenza vaccine created us swine flu scare president gerald ford confronted potential swine flu pandemic vaccination program rushed yet plagued delays public relations problems meanwhile maximum military containment efforts succeeded unexpectedly confining new strain single army base originated base number soldiers fell severely ill one died program canceled population received vaccinations excess deaths normal annual levels well excess hospitalizations syndrome estimated occurred vaccination program demonstrating vaccine free risks result cited support lingering doubts vaccination well counter ungrounded claims safety end however even maligned vaccine may saved lives study found significantly enhanced immune response pandemic study participants received vaccination swine flu swine flu outbreak resulted rapid approval pandemic influenza pandemrix quickly modified target circulating strain late million people received eight years later bmj gained access vaccine pharmacovigilance reports compiled gsk glaxosmithkline pandemic bmj reported indicated death fold likely pandemrix vs pandemic quadrivalent flu vaccine administered nasal mist approved fda march fluarix quadrivalent approved fda december canadian national advisory committee immunization naci published review quadrivalent influenza starting influenza season regulardose eggbased flu shots recombinant cellgrown flu vaccines united states influenza season regulardose flu shots recombinant influenza vaccine united states november fda approved fluzone highdose quadrivalent use united states starting influenza february fda approved fluad quadrivalent use united july fda approved fluad fluad quadrivalent use united states influenza byamagata lineage influenza b one four lineages targeted quadrivalent vaccines might become extinct due pandemic naturally occurring cases confirmed since march world health organization concluded protection yamagata lineage longer necessary seasonal flu vaccine future vaccines recommended trivalent instead us centers disease control prevention cdc recommends flu vaccine best way protect people flu prevent flu vaccine also reduce severity flu person contracts strain vaccine takes two weeks following vaccination protective antibodies metaanalysis found flu vaccination effective percent time populations benefited hivpositive adults aged percent healthy adults aged approximately percent healthy children aged six months months influenza vaccine also appears protect myocardial infarction benefit vaccine assessed efficacy extent reduces risk disease controlled conditions effectiveness observed reduction risk vaccine put case influenza effectiveness expected lower efficacy measured using rates influenzalike illness always caused studies effectiveness flu vaccines real world difficult vaccines may imperfectly matched virus prevalence varies widely years influenza often confused influenzalike however years years flu vaccine strains good match circulating even mismatched vaccine often provide virus rapidly changes due antigenic drift slight mutation virus causes new strain effectiveness seasonal flu vaccines varies significantly estimated average efficacy symptomatic depending vaccine strain age prior immunity immune function vaccinated people still contract effectiveness flu vaccines considered suboptimal particularly among vaccination still beneficial reducing mortality rate hospitalization rate due influenza well duration vaccination schoolage children shown provide indirect protection age groups laivs recommended children based superior efficacy especially children greater immunity nonvaccine strains compared inactivated new zealand vaccine effectiveness admission intensive care unit effectiveness hospitalized influenza illness united states flu season overall people aged years one review found effectiveness death among repeated annual influenza vaccination generally offer consistent yearonyear protection however suggestive evidence repeated vaccinations may cause reduction vaccine effectiveness certain influenza subtypes relevance current recommendations yearly vaccinations might influence future vaccination cdc recommends yearly vaccine studies demonstrate overall effectiveness annual influenza enough evidence establish significant differences effectiveness different influenza vaccine highdose adjuvanted products induce stronger immune response according study faculty university new south wales getting flu shot effective better preventing heart attack even quitting april advisory committee immunization practices acip encouraged children months age vaccinated annually acip recommended annual influenza vaccination months age currently cdc recommends everyone except infants age six months receive seasonal influenza vaccination campaigns usually focus special attention people high risk serious complications catch flu pregnant women children months elderly people chronic illnesses weakened immune systems well exposed health care death rate also high among infants catch influenza cdc recommend household contacts caregivers infants vaccinated reduce risk passing influenza infection children vaccine appears decrease risk influenza possibly influenzalike children age two data flu season cdc director indicated percent children died likely united states january cdc recommend children aged six months may receive either milliliters milliliters per dose fluzone preference one dose volume fluzone quadrivalent age persons months age older receive milliliters per dose fluzone october afluria quadrivalent licensed children six months age older united children six months months age receive milliliters dose afluria persons months age older receive milliliters per dose afluria february afluria tetra licensed adults children five years age older canadian national advisory committee immunization naci published review influenza vaccination healthy published review use pediatric fluad children months one study conducted tertiary referral center rate influenza vaccination children higher rates found among immunosuppressed pediatric patients patients inflammatory bowel disease unvaccinated adults get symptoms similar flu vaccinated adults vaccination decreased confirmed cases influenza effect hospitalization working adults review cochrane collaboration found vaccination resulted modest decrease influenza symptoms working days lost without affecting transmission influenzarelated healthy working adults influenza vaccines provide moderate protection virologically confirmed influenza though protection greatly reduced absent health care workers review found net eighteen studies review two also assessed relationship patient mortality relative staff influenza vaccine uptake found higher rates health care worker vaccination correlated reduced patient review found benefits patients health care workers immunized supported moderate based part observed reduction allcause deaths patients whose health care workers given immunization compared comparison patients workers offered evidence effect adults systematic reviews examining randomized controlled studies found lack highquality reviews studies found effects laboratoryconfirmed influenza pneumonia death among communitydwelling group vulnerable nonpandemic flu elderly benefits least vaccine multiple reasons behind steep decline vaccine efficacy common declining immunological function frailty associated advanced nonpandemic year person united states aged nearly ten times likely die influenzaassociated death younger person person ten times likely die influenzaassociated death age highdose flu vaccine specifically formulated provide stronger immune available evidence indicates vaccinating elderly highdose vaccine leads stronger immune response influenza regulardose flu vaccine containing adjuvant approved us food drug administration fda november use adults aged years age older vaccine marketed fluad us first available flu season vaccine contains oilinwater emulsion squalene oil first adjuvanted seasonal flu vaccine marketed united clear significant benefit elderly use flu vaccine containing per advisory committee immunization practices guidelines fluad used alternative influenza vaccines approved people years vaccinating health care workers work elderly people recommended many countries goal reducing influenza outbreaks vulnerable conclusive evidence randomized clinical trials vaccinating health care workers helps protect elderly people influenza tentative evidence fluad quad approved use australia september fluad quadrivalent approved use united states february fluad tetra approved use european union may well protecting mother child effects influenza infection immunization pregnant women tends increase chances experiencing successful fullterm trivalent inactivated influenza vaccine protective pregnant women infected common side effects vaccination include local injectionsite reactions coldlike symptoms fever malaise myalgia less common flu vaccines contraindicated people experienced severe allergic reaction response flu vaccine component vaccine laivs given children adolescents severe immunodeficiency using salicylate treatments risk developing reye laivs also recommended children age pregnant women adults immunosuppression inactivated flu vaccines cause influenza regarded safe side effects flu vaccine may occur usually minor including soreness redness swelling around point injection headache fever nausea side effects nasal spray vaccine may include runny nose wheezing sore throat cough people flu vaccine may cause serious side effects including allergic reaction rare furthermore common side effects risks mild temporary compared risks severe health effects annual influenza although syndrome feared complication vaccination cdc states studies modern influenza vaccines seen link infection influenza virus increases risk death one ten thousand risk developing syndrome far higher level highest level suspected vaccine involvement approximately ten times higher although one review gives incidence one case per million large study china covering close hundred million doses vaccine swine flu found eleven cases syndrome per million doses total incidence persons vaccinated actually lower normal rate disease china notable side although influenza vaccines produced using eggbased techniques influenza vaccines nonetheless still recommended safe people egg allergies even increased risk allergic reaction eggbased vaccines shown people egg studies examining safety influenza vaccines people severe egg allergies found anaphylaxis rare occurring cases per million doses monitoring symptoms vaccination recommended severe study nearly children egg allergy including previous anaphylactic reactions zero systemic allergic reactions given live attenuated flu vaccines produced using technologies notably recombinant vaccines based cell culture rather egg protein started become available later several studies identified increased incidence narcolepsy among recipients pandemic influenza efforts identify mechanism suggest narcolepsy autoimmune vaccine may mimic hypocretin serving injectionbased flu vaccines intended adults united states contain thiomersal also known thimerosal mercurybased despite controversy world health organizations global advisory committee vaccine safety concluded evidence toxicity thiomersal vaccines reason grounds safety change moreexpensive singledose seasonal flu vaccines available either ascitation needed tiv qiv induce protection injection typically intramuscular though subcutaneous intradermal routes also based immune response antigens present inactivated virus coldadapted laiv works establishing infection nasal various public health organizations including world health organization recommend yearly influenza vaccination routinely offered particularly people risk complications influenza individuals live care highrisk individuals including flu vaccine contraindicated six months age severe lifethreatening allergies flu vaccine ingredient world health organization recommends seasonal influenza vaccination first priority second priority particular order national advisory committee immunization naci group advises public health agency canada recommends everyone six months age encouraged receive annual influenza vaccination children age six months months household contacts considered high priority flu particularly live attenuated influenza vaccine laiv available canada european centre disease prevention control ecdc recommends vaccinating elderly priority secondary priority people chronic medical conditions health care influenza vaccination strategy generally protecting vulnerable people rather limiting influenza circulation eliminating human influenza sickness contrast high herd immunity strategies infectious diseases polio also due part financial logistics burden associated need annual united states routine influenza vaccination recommended persons aged six months takes two weeks vaccination sufficient antibodies develop cdc recommends vaccination end although considers getting vaccine december even later still according cdc live attenuated virus comes form nasal spray us avoided within blanket recommendation general vaccination united states cdc began recommending influenza vaccine health care workers emphasizes clinicians special urgency vaccination members certain vulnerable groups caregivers us government requires hospitals report worker vaccination rates us states hundreds us hospitals require health care workers either get vaccinations wear masks flu season requirements occasionally engender union lawsuits narrow collective bargaining grounds proponents note courts generally endorsed forced vaccination laws affecting general population disease vaccination influenza especially considered important members highrisk groups would likely complications influenza example pregnant children teenagers six months years age receiving aspirin salicylatecontaining medications might risk experiencing reye syndrome influenza virus cdc indicated live attenuated influenza vaccine laiv also called nasal spray vaccine recommended flu season united furthermore cdc recommends health care personnel care severely immunocompromised persons receive injections tiv qiv rather australian government recommends seasonal flu vaccination everyone age six months australia uses inactivated eggbased vaccine one available continues free one march new cellbased vaccine available wish pay expected one become standard standard flu vaccine free following uptake flu vaccination seasonally pandemics often systematic reviews pandemic flu vaccination uptake identified several personal factors may influence uptake including gender higher uptake men ethnicity higher people ethnic minorities chronic beliefs safety effectiveness vaccine also number measures found useful increase rates vaccination sixty including patient reminders using leaflets letters postcard reminders client outreach programs vaccine home visits group vaccinations free vaccinations physician payment physician reminders encouraging physician frontline health care workers often recommended get seasonal pandemic flu vaccination example uk health care workers involved patient care recommended receive seasonal flu vaccine also recommended vaccinated later renamed swine flu virus pandemic however uptake often pandemic low uptake healthcare workers seen countries including hong survey united states health care workers reported received flu vaccine season increase reported previous season us health professionals direct patient contact higher vaccination uptake physicians dentists nurse practitioners main reason vaccinate health care workers prevent staff spreading flu patients reduce staff absence time high service demand reasons health care workers state decisions accept decline vaccination may often perceived personal victoria australia public hospitals rates health care worker vaccination ranged nonclinical staff laboratory staff one reasons rejecting vaccines concern adverse reactions one study resident physicians teaching hospital incorrectly believed australian vaccines could cause research continues idea universal influenza vaccine would require tailoring particular strain would effective broad variety influenza vaccine candidates announced november several universal vaccines candidates preclinical development clinical report global capacity approximately million seasonal influenza vaccine doses inactivated live double production million doses aggressive scenario producing pandemic influenza vaccines billion courses could produced sixmonth time frame high uppermiddleincome countries sought vaccines entire populations pandemic nearly two billion courses would required china pursued goal well three billion courses would required serve vaccine research development ongoing identify novel vaccine approaches could produce much greater quantities vaccine price affordable global populationcitation needed flu vaccines grown vaccine manufacturers fertilized chicken northern hemisphere manufacturing process begins following announcement typically february recommended strains winter flu three strains representing b strain flu selected chicken eggs inoculated separately monovalent harvests combined make trivalent november conventional injection nasal spray manufactured using chicken eggs european union also approved optaflu vaccine produced novartis using vats animal cells technique expected scalable avoid problems eggs allergic reactions incompatibility strains affect avians like influenza vaccines produced pathogenfree eggs eleven twelve days top egg disinfected wiping alcohol egg candled identify nonveinous area allantoic cavity small hole poked serve pressure second hole made top egg influenza virus injected allantoic cavity past chorioallantoic membrane two holes sealed melted paraffin inoculated eggs incubated hours degrees incubation time virus replicates newly replicated viruses released allantoic incubation period top egg cracked ten milliliters allantoic fluid removed fifteen micrograms flu vaccine obtained point viruses weakened killed viral antigen purified placed inside vials syringes nasal eggs needed produce one dose trivalent vaccine estimated million eggs produced year flu vaccine methods vaccine generation bypass need eggs include construction influenza viruslike particles vlp vlp resemble viruses need inactivation include viral coding elements merely present antigens similar manner virion methods producing vlp include cultures spodoptera frugiperda insect cells plantbased vaccine production eg production nicotiana benthamiana evidence vlps elicit antibodies recognize broader panel antigenically distinct viral isolates compared vaccines hemagglutinationinhibition assay genebased dna vaccine used prime immune system boosting inactivated vaccine underwent clinical trials november novartis received fda approval first cellculture recombinant influenza vaccine flublok approved use united september committee medicinal products human use chmp european medicines agency ema adopted positive opinion recommending granting marketing authorization supemtek quadrivalent influenza vaccine recombinant prepared cell applicant medicinal product sanofi supemtek approved medical use european union november australia authorised first cellbased vaccine march based eternal cell line dog kidney way produced produces bettermatched vaccine flu according countries influenza vaccine produced addition kazakhstan serbia thailand facilities final stages establishing costeffectiveness seasonal influenza vaccination widely evaluated different groups different elderly majority published studies found vaccination cost saving cost savings associated influenza vaccination eg prevented health care visits outweighing cost older adults aged years several published studies found influenza vaccination likely costeffective however results studies often found dependent key assumptions used economic uncertainty influenza costeffectiveness models partially explained complexities involved estimating disease well seasonal variability circulating strains match healthy working adults aged years review found vaccination generally costsaving suitability funding dependent willingness pay obtain associated health children majority studies found influenza vaccination costeffective however many studies included indirect productivity gains may given weight several studies attempted predict costeffectiveness interventions including prepandemic vaccination help protect future pandemic however estimating costeffectiveness complicated uncertainty severity potential future pandemic efficacy measures influenza research includes molecular virology molecular evolution pathogenesis host immune responses genomics epidemiology help developing influenza countermeasures vaccines therapies diagnostic tools improved influenza countermeasures require basic research viruses enter cells replicate mutate evolve new strains induce immune response influenza genome sequencing project creating library influenza help researchers understanding makes one strain lethal another genetic determinants affect immunogenicity virus evolves time solutions limitations currentwhen vaccine methods beingwhen researched different approach uses internet content estimate impact influenza vaccination campaign specifically researchers used data twitter microsofts bing search engine proposed statistical framework series operations maps information estimates influenzalike illness reduction percentage areas vaccinations performed method used quantify impact two flu vaccination programmes england schoolage children administered live attenuated influenza vaccine laiv notably impact estimates accordance estimations public health england based traditional syndromic surveillance rapid development production distribution pandemic influenza vaccines could potentially save millions lives influenza pandemic due short time frame identification pandemic strain need vaccination researchers looking novel technologies vaccine production could provide better realtime access produced affordably thereby increasing access people living low moderateincome countries influenza pandemic may likely originate live attenuated eggbased cellbased technology recombinant technologies proteins viruslike july seventy known clinical trials completed ongoing pandemic influenza september fda approved four vaccines influenza virus pandemic strain expected initial vaccine lots available within following january us food drug administration fda approved audenz vaccine flu audenz vaccine indicated active immunization prevention disease caused influenza virus subtype contained vaccine audenz approved use persons six months age older increased risk exposure influenza virus subtype contained universal influenza vaccine would designed made flu season hemisphere would stabilize supply avoid error predicting seasons variants protect escape circulating strains vaccine subject research one approach use broadly neutralizing antibodies unlike annual seasonal vaccines used first decades century provoke body generate immune response instead provide component immune response first neutralizing antibodies identified via found flu neutralizing antibodies bound stalk hemagglutinin protein antibodies could bind head proteins identified highly conserved proton channel proposed potential target broadly neutralizing challenges researchers identify single antibodies could neutralize many subtypes virus could useful season target conserved domains resistant antigenic another approach take conserved domains identified projects deliver groups antigens provoke immune response various approaches different antigens presented different ways fusion proteins mounted viruslike particles nonpathogenic viruses dna others efforts also undertaken develop universal vaccines specifically activate tcell response based clinical data showing people strong early tcell response better outcomes infected influenza tcells respond conserved epitopes challenge developers epitopes internal protein domains mildly along rest vaccine field people working universal vaccines experimented vaccine adjuvants improve ability vaccines create sufficiently powerful enduring immune oral flu vaccine clinical oral vaccine candidate based adenovirus type vector modified remove genes needed replication added gene expresses small doublestranded rna hairpin molecule phase ii human trial pill form vaccine showed well tolerated provided similar immunity licensed injectable influenza vaccine vaccine may given safely preliminary research indicates influenza vaccination prevent may reduce incidence severity tom jefferson led cochrane collaboration reviews flu vaccines called clinical evidence concerning flu vaccines rubbish therefore declared ineffective called placebocontrolled randomized clinical trials field hold unethical views efficacy flu vaccines rejected medical institutions including cdc national institutes health key figures field like anthony michael osterholm led center infectious disease research policy review flu vaccines recommended getting vaccine criticized promotion saying overpromoted overhyped vaccine protect promoted sales job public veterinary influenza vaccination aims achieve following four horses horse flu run fever dry hacking cough runny nose become depressed reluctant eat drink several days usually recover two three weeks vaccination schedules generally require primary course two doses weeks apart followed boosters month intervals generally recognized many cases schedules may maintain protective levels antibody frequent administration advised highrisk common requirement shows united kingdom horses vaccinated equine flu vaccination card must produced international federation equestrian sports fei requires vaccination every six poultry vaccines bird flu made inexpensively filtered purified like human vaccines remove bits bacteria viruses usually contain whole virus hemagglutinin human flu vaccines another difference human poultry vaccines poultry vaccines adjuvated mineral oil induces strong immune reaction cause inflammation abscesses chicken vaccinators accidentally jabbed developed painful swollen fingers even lost thumbs doctors said effectiveness may also limited chicken vaccines often vaguely similar circulating flu strains contain strain isolated mexico years ago chicken use vaccine thats percent related youll get protection dr cardona said humans get single point mutation vaccine thats percent related wont protect weaker human vaccines chickens smaller need protect six weeks thats long live till eat said dr john j treanor vaccine expert university rochester human seasonal flu vaccines contain micrograms antigen experimental vaccine contains chicken vaccines may contain less one microgram careful extrapolating data poultry humans warned dr david e swayne director agriculture departments southeast poultry research laboratory birds closely related researchers led nicholas savill university edinburgh scotland used mathematical models simulate spread concluded least percent birds need protected prevent virus spreading silently practice difficult protect percent flock protection levels achieved vaccine usually much lower food agriculture organization united nations issued recommendations prevention control avian influenza poultry including use filtered purified influenza vaccine humans developedwhen many countries recommended stockpiled avian influenza pandemic starts jumping humans vaccine quickly administered avoid loss life avian influenza sometimes called avian flu commonly bird swine influenza vaccines extensively used pig farming europe north america swine flu vaccines include strain swine influenza recognized major problem since outbreak evolution virus resulted inconsistent responses traditional vaccines standard commercial swine flu vaccines effective controlling problem virus strains match enough significant crossprotection customised autogenous vaccines made specific viruses isolated made used difficult vaccine manufacturer novartis claims strain first identified brought major losses pig farmers abortion storms common sign sows stop eating days run high fever mortality rate high fifteen influenza virus subtype discovered cause canine influenza lack previous exposure virus dogs natural immunity virus however vaccine found year three strains chosen selection years flu vaccination global influenza surveillance response chosen strains typeb strains thought likely cause significant human suffering coming season starting northern hemisphere influenza season coincident approval quadrivalent influenza vaccines also recommended bstrain use quadrivalent vaccines world health organization coordinates contents vaccine year contain likely strains virus attack next year global influenza surveillance response systems selection viruses vaccine manufacturing process based best estimate strains predominate next year amounting end wellinformed fallible formal recommendations first issued beginning two recommendations per year one northern hemisphere southern httpsenwikipediaorgwikiinfluenzavaccine